Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Duvortuxizumab Biosimilar – Anti-CD19, CD3E mAb – Research Grade

  • PX-TA1432
Clonality:
Monoclonal Antibody
Isotype:
scFv -h-CH2-CH3(_scFv)_h-CH2-CH3

200.00

+ 200 loyalty points
Size
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery

Duvortuxizumab Biosimilar - Anti-CD19, CD3E mAb - Research Grade

Product name Duvortuxizumab Biosimilar - Anti-CD19, CD3E mAb - Research Grade
Source CAS 1831098-91-9
Species Chimeric,Humanized
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Duvortuxizumab,JNJ-64052781,MGD011,RES192M1.2,CD19, CD3E,anti-CD19, CD3E
Reference PX-TA1432
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype scFv -h-CH2-CH3(_scFv)_h-CH2-CH3
Clonality Monoclonal Antibody
Product name Duvortuxizumab Biosimilar - Anti-CD19, CD3E mAb - Research Grade
Source CAS 1831098-91-9
Species Chimeric,Humanized
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Duvortuxizumab,JNJ-64052781,MGD011,RES192M1.2,CD19, CD3E,anti-CD19, CD3E
Reference PX-TA1432
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype scFv -h-CH2-CH3(_scFv)_h-CH2-CH3
Clonality Monoclonal Antibody

General information on Anti-CD19/CD3E[Homo sapiens] (Duvortuxizumab) Monoclonal Antibody

Duvortuxizumab is investigated for the treatment of Lymphoma.

There are no reviews yet.

Be the first to review “Duvortuxizumab Biosimilar – Anti-CD19, CD3E mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products